Medicine. Stroke--tPA and the clinic.
Publication
, Journal Article
Marler, JR; Goldstein, LB
Published in: Science
September 19, 2003
Clinical trial results are not always rapidly incorporated into routine medical practice. This Policy Forum describes a variety of barriers that have impeded the more widespread use of thrombolytic therapy (tPA, tissue plasminogen activator) for selected patients with acute ischemic stroke. These barriers are not insurmountable but will require a concerted effort to overcome.
Duke Scholars
Published In
Science
ISSN
1095-9203
Publication Date
September 19, 2003
Volume
301
Issue
5640
Start / End Page
1677
Related Subject Headings
- General Science & Technology
Citation
APA
Chicago
ICMJE
MLA
NLM
Marler, J. R., & Goldstein, L. B. (2003). Medicine. Stroke--tPA and the clinic. Science, 301(5640), 1677.
Marler, J. R., and L. B. Goldstein. “Medicine. Stroke--tPA and the clinic.” Science 301, no. 5640 (September 19, 2003): 1677.
Marler JR, Goldstein LB. Medicine. Stroke--tPA and the clinic. Science. 2003 Sep 19;301(5640):1677.
Marler, J. R., and L. B. Goldstein. “Medicine. Stroke--tPA and the clinic.” Science, vol. 301, no. 5640, Sept. 2003, p. 1677.
Marler JR, Goldstein LB. Medicine. Stroke--tPA and the clinic. Science. 2003 Sep 19;301(5640):1677.
Published In
Science
ISSN
1095-9203
Publication Date
September 19, 2003
Volume
301
Issue
5640
Start / End Page
1677
Related Subject Headings
- General Science & Technology